MedTrace Logo

Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study

NCT02949297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2021-12-22

Study results available
· View outcomes & findings →

Summary

A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA).

Conditions

  • Aortic Aneurysm, Abdominal

Interventions

DEVICE

Ovation Alto Abdominal Stent Graft System

Repair of Abdominal Aortic Aneurysm with Ovation Alto Abdominal Stent Graft System

Sponsors & Collaborators

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Sean Lyden, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2019-03-06
Completion
2019-03-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02949297 on ClinicalTrials.gov